Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer

NCT05934461 is registered in ClinicalTrials.gov with Laibin People's Hospital as lead sponsor.

NCT NCT05934461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05934461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study of Radiotherapy Combined With EGFR-TKI for Stage III EGFR Mutant Lung Cancer
Lead sponsor
Laibin People's Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2014
Completion date
June 1, 2023
Enrollment
48 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

the primary study metric is progression-free survival (pfs)